We hypothesised that eGlx HS plays a key role in the barrier properties of retinal and glomerular capillaries and that inhibiting heparanase to protect eGlx HS, could serve as a novel systemic approach to protect against microvascular complications in diabetes. The gene discussed is HPSE; the disease is diabetes mellitus.